Lv0
0 积分 2020-07-12 加入
Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes
4个月前
已完结
Finerenone and eGFR Slope across Different Levels of Baseline Albuminuria and eGFR
4个月前
已完结
The effect of renal function on the pharmacokinetics and pharmacodynamics of enavogliflozin, a potent and selective sodium‐glucose cotransporter‐2 inhibitor, in type 2 diabetes
4个月前
已完结
Effect of sotagliflozin on major adverse cardiovascular events: a prespecified secondary analysis of the SCORED randomised trial
4个月前
已完结
Kidney, Cardiovascular, and Safety Outcomes of Canagliflozin according to Baseline Albuminuria: A CREDENCE Secondary Analysis
4个月前
已完结
Effects of Dapagliflozin on Health-Related Quality of Life in Patients with CKD
4个月前
已完结
Finerenone in People with Chronic Kidney Disease, Type 2 Diabetes, and History of Nephrectomy
4个月前
已完结
皖公网安备34019202002308
